803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797632741867520000 |
|---|---|
| author | Philip D Greenberg Valentin Voillet Raphael Gottardo Kristin G Anderson Breanna M Bates Madison G Burnett Susan L Ruskin Yapeng Su Magdalia L Suarez Gutierrez |
| author_facet | Philip D Greenberg Valentin Voillet Raphael Gottardo Kristin G Anderson Breanna M Bates Madison G Burnett Susan L Ruskin Yapeng Su Magdalia L Suarez Gutierrez |
| author_sort | Philip D Greenberg |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:41:07Z |
| format | Article |
| id | doaj.art-02aa15847e644c8caf9301b40b6a786b |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:41:07Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-02aa15847e644c8caf9301b40b6a786b2023-11-10T02:30:06ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0803803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancerPhilip D Greenberg0Valentin Voillet1Raphael Gottardo2Kristin G Anderson3Breanna M Bates4Madison G Burnett5Susan L Ruskin6Yapeng Su7Magdalia L Suarez Gutierrez85University of Washington School of Medicine, Seattle, WA, USAFred Hutchinson Cancer Research Center, Seattle, Washington, USAFred Hutchinson Cancer Research Center, Seattle, Washington, USA2 University of Virginia Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USAClinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAClinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAClinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA3Fred Hutchinson Cancer Center, Seattle, WA, USA3Fred Hutchinson Cancer Center, Seattle, WA, USA |
| spellingShingle | Philip D Greenberg Valentin Voillet Raphael Gottardo Kristin G Anderson Breanna M Bates Madison G Burnett Susan L Ruskin Yapeng Su Magdalia L Suarez Gutierrez 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer Journal for ImmunoTherapy of Cancer |
| title | 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer |
| title_full | 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer |
| title_fullStr | 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer |
| title_full_unstemmed | 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer |
| title_short | 803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer |
| title_sort | 803 triple checkpoint blockade but not anti pd1 alone enhances the efficacy of engineered adoptive t cell therapy in advanced ovarian cancer |
| work_keys_str_mv | AT philipdgreenberg 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT valentinvoillet 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT raphaelgottardo 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT kristinganderson 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT breannambates 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT madisongburnett 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT susanlruskin 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT yapengsu 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer AT magdalialsuarezgutierrez 803triplecheckpointblockadebutnotantipd1aloneenhancestheefficacyofengineeredadoptivetcelltherapyinadvancedovariancancer |